0
Editor's Correspondence |

Virologic Response Associated With a Change in Protease Inhibitor Therapy

David Butcher, MD; Jeffrey Greene, MD; Phong Duong, PharmD; Leona Markson, ScD
Arch Intern Med. 2000;160(3):393-394. doi:.
Text Size: A A A
Published online

Extract

In the report by Guardiola and colleagues,1 a switch in protease inhibitor (PI) therapy for reasons other than therapeutic failure occurred in 74% of patients who were treated with PI-based regimens. The therapeutic strategy in these patients needs careful assessment before PI changes, since the patients may be put at greater risk for therapeutic failure after therapy change.

Figure 1 shows the virologic response in 14 patients who had a switch in PI after having achieved viral RNA suppression (viral RNA load <400 copies per milliliter) compared with 28 patients who continued to receive a successful regimen. Patients from 2 clinics were included in this retrospective chart review if they were treated with an indinavir sulfate regimen for at least 6 months and had 2 viral RNA measures below detection while receiving indinavir-combination therapy.2 From this group, patients were further identified for the switch group if their PI therapy had changed from indinavir to nelfinavir mesylate and if they had at least 1 viral RNA measurement after the PI switch (t0). Patients who continued to receive indinavir regimens constituted the comparison group. Two comparison patients per nelfinavir switch patient were randomly selected and matched for status of PI use prior to indinavir treatment and start date of indinavir treatment. Each comparison patient was assigned a date that allowed a time receiving indinavir equal to the time receiving indinavir of the matched patient who switched to nelfinavir. Patients in both groups had to have evidence of viral RNA suppression in the 3 months prior to t0. In the nelfinavir switch patients without a documented reason for PI change, the patients also had to have documented undetectable viral RNA (viral RNA load <400 copies per milliliter) within 4 weeks after the switch, indicating that the PI change was not a result of therapeutic failure. In Kaplan-Meier analysis, the last viral RNA measure available for each patient was defined as censored if viral RNA was undetectable and no further observations were available or as indicative of failure if the viral RNA load was greater than 400 copies per milliliter.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption

Kaplan-Meier plot of the proportion of 14 patients with viral RNA loads less than 400 copies per milliliter after a switch in protease inhibitor therapy compared with 28 patients who continued to receive a successful regimen. t0 indicates the time protease inhibitor therapy was switched.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 4

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();